The Latin America, Middle East and Africa Peripheral Vascular Stents Market would witness market growth of 11.8% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 241.0 thousand units, showcasing a growth of 12.9% (2023-2030).
Stents offer potential benefits such as reduced long-term complications and the ability to adapt to vessel changes as they dissolve. There are ongoing efforts to increase awareness of PAD and its associated risk factors. As awareness grows, an increased demand for treatments, including peripheral vascular stents, will likely increase. As healthcare systems shift toward preventive and proactive approaches, early detection and management of vascular diseases become more critical. This drives the adoption of stents as part of comprehensive treatment plans. Expanding healthcare infrastructure in emerging markets increases accessibility to advanced medical devices and procedures, including peripheral vascular stents.
The adoption of these stents often depends on advancements in stent technology. As stents become more sophisticated, durable, and minimally invasive, healthcare providers are more likely to adopt them in their practice. A trend in healthcare is the preference for minimally invasive procedures. Stents can often be placed using minimally invasive techniques, leading to increased adoption due to reduced patient recovery times and lower risks.
Saudi Arabia has become an increasingly active participant in clinical trials related to peripheral vascular stents. These trials generate valuable data on the safety and efficacy of different stent technologies and treatment approaches. The Saudi Arabian government has invested in healthcare infrastructure and research, including funding for clinical studies and trials related to vascular diseases and stent technologies. Hospitals and healthcare systems in Saudi Arabia engage in quality improvement initiatives that involve analyzing clinical data and outcomes, leading to continuous enhancements in patient care and stent procedures. All of these developments will propel the expansion of the regional market in the coming years.
The Brazil market dominated the LAMEA Peripheral Vascular Stents Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $55.4 million by 2030. The Argentina market is showcasing a CAGR of 12.4% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 11.5% during (2023 - 2030).
Based on Mode of Delivery, the market is segmented into Balloon-expandable Stents, and Self-expanding Stents. Based on End-use, the market is segmented into Hospitals & Cardiac Centers, Ambulatory Surgical Centers, and Others. Based on Product, the market is segmented into Iliac Artery Stents, Femoral Artery Stents, Carotid Artery Stents, Renal Artery Stents, and Others. Based on Stents Type, the market is segmented into Drug Eluting Stents (DES), Bare Metal Stents (BMS), and Bioabsorbable Stents. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, Abbott Laboratories, Biotronik SE & Co. KG, Stryker Corporation, Cook Medical, Inc. (Cook Group), MicroPort Scientific Corporation, LifeTech Scientific Corporation and iVascular S.L.U.
Stents offer potential benefits such as reduced long-term complications and the ability to adapt to vessel changes as they dissolve. There are ongoing efforts to increase awareness of PAD and its associated risk factors. As awareness grows, an increased demand for treatments, including peripheral vascular stents, will likely increase. As healthcare systems shift toward preventive and proactive approaches, early detection and management of vascular diseases become more critical. This drives the adoption of stents as part of comprehensive treatment plans. Expanding healthcare infrastructure in emerging markets increases accessibility to advanced medical devices and procedures, including peripheral vascular stents.
The adoption of these stents often depends on advancements in stent technology. As stents become more sophisticated, durable, and minimally invasive, healthcare providers are more likely to adopt them in their practice. A trend in healthcare is the preference for minimally invasive procedures. Stents can often be placed using minimally invasive techniques, leading to increased adoption due to reduced patient recovery times and lower risks.
Saudi Arabia has become an increasingly active participant in clinical trials related to peripheral vascular stents. These trials generate valuable data on the safety and efficacy of different stent technologies and treatment approaches. The Saudi Arabian government has invested in healthcare infrastructure and research, including funding for clinical studies and trials related to vascular diseases and stent technologies. Hospitals and healthcare systems in Saudi Arabia engage in quality improvement initiatives that involve analyzing clinical data and outcomes, leading to continuous enhancements in patient care and stent procedures. All of these developments will propel the expansion of the regional market in the coming years.
The Brazil market dominated the LAMEA Peripheral Vascular Stents Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $55.4 million by 2030. The Argentina market is showcasing a CAGR of 12.4% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 11.5% during (2023 - 2030).
Based on Mode of Delivery, the market is segmented into Balloon-expandable Stents, and Self-expanding Stents. Based on End-use, the market is segmented into Hospitals & Cardiac Centers, Ambulatory Surgical Centers, and Others. Based on Product, the market is segmented into Iliac Artery Stents, Femoral Artery Stents, Carotid Artery Stents, Renal Artery Stents, and Others. Based on Stents Type, the market is segmented into Drug Eluting Stents (DES), Bare Metal Stents (BMS), and Bioabsorbable Stents. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, Abbott Laboratories, Biotronik SE & Co. KG, Stryker Corporation, Cook Medical, Inc. (Cook Group), MicroPort Scientific Corporation, LifeTech Scientific Corporation and iVascular S.L.U.
Scope of the Study
Market Segments Covered in the Report:
By Mode of Delivery (Volume, Thousand Units, USD Million, 2019-2030)- Balloon-expandable Stents
- Self-expanding Stents
- Hospitals & Cardiac Centers
- Ambulatory Surgical Centers
- Others
- Iliac Artery Stents
- Femoral Artery Stents
- Carotid Artery Stents
- Renal Artery Stents
- Others
- Drug Eluting Stents (DES)
- Bare Metal Stents (BMS)
- Bioabsorbable Stents
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- Medtronic PLC
- Terumo Corporation
- Abbott Laboratories
- Biotronik SE & Co. KG
- Stryker Corporation
- Cook Medical, Inc. (Cook Group)
- MicroPort Scientific Corporation
- LifeTech Scientific Corporation
- iVascular S.L.U.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market At a Glance
Chapter 3. Market Overview
Chapter 5. LAMEA Peripheral Vascular Stents Market by Mode of Delivery
Chapter 6. LAMEA Peripheral Vascular Stents Market by End-use
Chapter 7. LAMEA Peripheral Vascular Stents Market by Product
Chapter 8. LAMEA Peripheral Vascular Stents Market by Stents Type
Chapter 9. LAMEA Peripheral Vascular Stents Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Boston Scientific Corporation
- Medtronic PLC
- Terumo Corporation
- Abbott Laboratories
- Biotronik SE & Co. KG
- Stryker Corporation
- Cook Medical, Inc. (Cook Group)
- MicroPort Scientific Corporation
- LifeTech Scientific Corporation
- iVascular S.L.U.
Methodology
LOADING...
